发明名称 O-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD
摘要 Formula (I) wherein Y is formula (a) or heteroaryl; A is -O(CH2)m, S, - NH(CH2)m, or (CH2)n where n is 0-3 and m is 0-2; and R1 to R6 are as defined herein. A method is also provided for treating diabetes and related diseases employing an SGLT2 inhibiting amount of the above compound alone or in combination with one, two or more other antidiabetic agents, and/or one, two or more hypolipidemic agents.
申请公布号 CA2404373(A1) 申请公布日期 2001.10.11
申请号 CA20012404373 申请日期 2001.03.29
申请人 BRISTOL-MYERS SQUIBB COMPANY 发明人 WU, GANG;SHER, PHILIP M.;WASHBURN, WILLIAM N.
分类号 A61K31/137;A61K31/155;A61K31/18;A61K31/192;A61K31/195;A61K31/198;A61K31/216;A61K31/22;A61K31/351;A61K31/357;A61K31/365;A61K31/40;A61K31/4035;A61K31/404;A61K31/421;A61K31/4245;A61K31/426;A61K31/427;A61K31/4418;A61K31/445;A61K31/4453;A61K31/64;A61K31/7034;A61K31/7056;A61K31/706;A61K38/26;A61K38/28;A61K45/00;A61P3/04;A61P3/06;A61P3/10;A61P7/12;A61P9/10;A61P9/12;A61P13/12;A61P17/02;A61P25/00;A61P27/02;C07B61/00;C07H15/203;C07H15/26;(IPC1-7):C07H15/203;A61K31/703 主分类号 A61K31/137
代理机构 代理人
主权项
地址